BPN14770 Single Ascending Dose Study in Healthy Male and Female Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This is a randomized double-blind (investigator and subject blinded), placebo controlled ascending single dose study to evaluate the safety, tolerability, and pharmacokinetic profile of BPN14770 in healthy male and female subjects. Each subject will be randomized to receive either a single dose of BPN14770 or placebo.
Epistemonikos ID: d8d446e798c0b32b284380d1606aa1344f427e73
First added on: May 12, 2024